Maintaining cleanroom compliance in sterile pharmaceutical manufacturing is essential for protecting product integrity, safeguarding worker health, and preventing contamination.
MyCondro™ is a fermentation-derived, non-animal chondroitin sulfate that redefines joint health and mobility. Clinically validated at 600 mg, it improves knee function, reduces pain, and lowers inflammation markers.
In these articles we’ll explore the main challenges of probiotic stability and practical ways to improve it during formulation, manufacturing, and storage.
Discover how the UK, one of the first countries in Europe to implement a national lung cancer screening programme, is using DeepHealth’s suite of AI and workflow applications to help radiologists report findings efficiently and consistently.
Although we did not know it in the 17th century, when a dog was injected using goose quills, we now understand that bacteria and other contaminants can cause serious harm to patients. That is why the final aseptic filling step is critical in the manufacture of injectable drugs.
Behind the microscopic landscape of our digestive system lies a fascinating world: the mycobiome - the community of fungi, including yeasts, that naturally reside within the human body. While bacteria have dominated discussions, probiotic yeasts emerge as nature’s skilled health builders.
This ebook explores how joint health innovation can help nutraceutical brands compete in the rapidly growing longevity market. It highlights mobility as a core pillar of healthspan, showing how consumers increasingly seek solutions that maintain activity, flexibility and independence as they age.
This e-book “Small Molecules: Choosing the Right Development Path” offers a structured roadmap for early CMC decision-making tailored to resource-constrained teams.
Patient safety is now closely linked to cyber resilience. As healthcare delivery organisations (HDOs) integrate IoT and medical devices (IoMT), they face rising risks from ransomware and legacy vulnerabilities.